Preventive Medicine Doctors in Long Island City, NY Accepting Medicare

4 Preventive Medicine doctors found. Showing 1 - 4

Dr. Winfred Y Wu, MD, MPH Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 4209 28th St, 12th Floor (cn-52), Long Island City, NY 11101 Phone: 347-396-4916

Allison Lemkin, M.D. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Medicare Enrolled Practice Location: 42-09 28th St, Long Island City, NY 11101 Phone: 212-639-9675

Anne Deborah Fine, M.D. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 4209 28th St, Bureau Of Communicable Disease, 6-01, Long Island City, NY 11101 Phone: 347-396-2612

Sujoy Gayen, Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 42-09 28th St, Long Island City, NY 11101 Phone: 212-639-9675

News Archive

Findings may help develop a new class of drugs for diabetes

More than half a century after researchers identified a promising way to treat diabetes based on blocking the breakdown of insulin in the body, a research team led by a scientist at the Mayo Clinic campus in Florida have developed potent molecules that can do just that.

No valid, adequate criteria for certifying an illness as terminal: Study

Physicians that have to decide whether an illness is terminal think that "there are not valid and adequate criteria for certifying that an illness is terminal". This is the conclusion drawn from a pioneer study conducted at the University of Granada, and recently published in the International Journal of Clinical and Health Psychology (IJCHP).

Aptuit to acquire GSK's research business in Verona

GlaxoSmithKline (GSK) and Aptuit, Inc. announced today that they have finalized an agreement for Aptuit to acquire operations at GSK's Medicines Research Centre in Verona, Italy. The arrangement, which is effective as of July 1, 2010, provides for ongoing employment of the staff at the centre and for Aptuit to supply GSK with R&D services from the facilities. Financial terms have not been disclosed.

Triple-negative breast cancer found to be chemoresistant prior to treatment

Difficult to treat and aggressive "triple-negative" breast cancer is chemoresistant even before chemotherapy begins, a new study by researchers from Karolinska Institutet and the University of Texas MD Anderson Cancer Center reports. The findings, which are published in the journal Cell, may lead to better and more personalized treatments for breast cancer.

Read more Medical News

› Verified 4 days ago